Literature DB >> 22422881

Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.

Shariq Mujib1, R Brad Jones, Calvin Lo, Nasra Aidarus, Kiera Clayton, Ali Sakhdari, Erika Benko, Colin Kovacs, Mario A Ostrowski.   

Abstract

T cell Ig mucin domain-containing molecule 3 (Tim-3) is a glycoprotein found on the surface of a subset of CD8(+) and Th1 CD4(+) T cells. Elevated expression of Tim-3 on virus-specific T cells during chronic viral infections, such as HIV-1, hepatitis B virus, and hepatitis C virus, positively correlates with viral load. Tim-3(+) cytotoxic T cells are dysfunctional and are unable to secrete effector cytokines, such as IFN-γ and TNF-α. In this study, we examined potential inducers of Tim-3 on primary human T cells. Direct HIV-1 infection of CD4(+) T cells, or LPS, found to be elevated in HIV-1 infection, did not induce Tim-3 on T cells. Tim-3 was induced by the common γ-chain (γc) cytokines IL-2, IL-7, IL-15, and IL-21 but not IL-4, in an Ag-independent manner and was upregulated on primary T cells in response to TCR/CD28 costimulation, as well as γc cytokine stimulation with successive divisions. γc cytokine-induced Tim-3 was found on naive, effector, and memory subsets of T cells. Tim-3(+) primary T cells were more prone to apoptosis, particularly upon treatment with galectin-9, a Tim-3 ligand, after cytokine withdrawal. The upregulation of Tim-3 could be blocked by the addition of a PI3K inhibitor, LY 294002. Thus, Tim-3 can be induced via TCR/CD28 costimulation and/or γc cytokines, likely through the PI3K pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422881     DOI: 10.4049/jimmunol.1102609

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  A review of the importance of immune responses in luminal B breast cancer.

Authors:  Delia J Nelson; Briony Clark; Kylie Munyard; Vincent Williams; David Groth; Jespal Gill; Henry Preston; Arlene Chan
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

2.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

3.  Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer.

Authors:  Gulidanna Shayan; Raghvendra Srivastava; Jing Li; Nicole Schmitt; Lawrence P Kane; Robert L Ferris
Journal:  Oncoimmunology       Date:  2016-12-23       Impact factor: 8.110

4.  A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.

Authors:  Theodore S Nowicki; Beata Berent-Maoz; Gardenia Cheung-Lau; Rong Rong Huang; Xiaoyan Wang; Jennifer Tsoi; Paula Kaplan-Lefko; Paula Cabrera; Justin Tran; Jia Pang; Mignonette Macabali; Ivan Perez Garcilazo; Ignacio Baselga Carretero; Anusha Kalbasi; Alistair J Cochran; Catherine S Grasso; Siwen Hu-Lieskovan; Bartosz Chmielowski; Begoña Comin-Anduix; Arun Singh; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

5.  Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.

Authors:  Jing Li; Gulidanna Shayan; Lyndsay Avery; Hyun-Bae Jie; Neil Gildener-Leapman; Nicole Schmitt; Bin Feng Lu; Lawrence P Kane; Robert L Ferris
Journal:  Oncoimmunology       Date:  2016-09-22       Impact factor: 8.110

6.  Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.

Authors:  Tsuyoshi Fujita; Benjamin J Burwitz; Glen M Chew; Jason S Reed; Reesab Pathak; Elizabeth Seger; Kiera L Clayton; James M Rini; Mario A Ostrowski; Naoto Ishii; Marcelo J Kuroda; Scott G Hansen; Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

7.  T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases.

Authors:  Kiera L Clayton; Matthew S Haaland; Matthew B Douglas-Vail; Shariq Mujib; Glen M Chew; Lishomwa C Ndhlovu; Mario A Ostrowski
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

8.  IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor.

Authors:  Yuying Liu; Nannan Zhou; Li Zhou; Jing Wang; Yabo Zhou; Tianzhen Zhang; Yi Fang; Jinwei Deng; Yunfeng Gao; Xiaoyu Liang; Jiadi Lv; Zhenfeng Wang; Jing Xie; Yuanbo Xue; Huafeng Zhang; Jingwei Ma; Ke Tang; Yiliang Fang; Feiran Cheng; Chengjuan Zhang; Bing Dong; Yuzhou Zhao; Peng Yuan; Quanli Gao; Haizeng Zhang; F Xiao-Feng Qin; Bo Huang
Journal:  Nat Immunol       Date:  2021-01-11       Impact factor: 25.606

Review 9.  Reversing T-cell Dysfunction and Exhaustion in Cancer.

Authors:  Hassane M Zarour
Journal:  Clin Cancer Res       Date:  2016-04-15       Impact factor: 12.531

10.  Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Authors:  Shariq Mujib; Jun Liu; A K M Nur-Ur Rahman; Jordan A Schwartz; Phil Bonner; Feng Yun Yue; Mario A Ostrowski
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.